Patrys Ltd (PAB)

Sydney
0.021
-0.001(-4.55%)
  • Volume:
    87,189
  • Bid/Ask:
    0.021/0.022
  • Day's Range:
    0.021 - 0.021

PAB Overview

Prev. Close
0.022
Day's Range
0.021-0.021
Revenue
2.77M
Open
0.021
52 wk Range
0.02-0.063
EPS
0
Volume
87,189
Market Cap
43.19M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
2,951,229
P/E Ratio
-
Beta
0.17
1-Year Change
-18.18%
Shares Outstanding
2,056,574,757
Next Earnings Date
-
What is your sentiment on Patrys Ltd?
or
Vote to see community's results!

Patrys Ltd News

Patrys Ltd Company Profile

Patrys Ltd Company Profile

Employees
10
Market
Australia

Patrys Limited is an Australia-based company, which is engaged in the development of antibody therapies for the treatment of cancer. The Company is engaged in developing the treatment of Glioblastoma (GBM) and Triple Negative Breast Cancer (TNBC). The Company has developed two forms of deoxymab 3E10, including PAX-DX1 and PAT-DX3. Its is also using the PAT-DX1 antibody to deliver nanoparticles carrying therapeutic payloads to the inside of cells. The Company is in the process of the first human clinical trial of PAT-DX1. Its two product candidates, PAT-DX2 and PAT-DX1-NP are under preclinical stage.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsSellSellNeutralStrong SellStrong Sell
SummaryStrong SellStrong SellSellStrong SellStrong Sell
  • takeover target in months to come
    0